KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Asset Utilization Ratio (2020 - 2025)

Royalty Pharma's Asset Utilization Ratio history spans 6 years, with the latest figure at 0.12 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 2.22% year-over-year to 0.12; the TTM value through Dec 2025 reached 0.12, down 2.22%, while the annual FY2025 figure was 0.13, 3.93% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.12 at Royalty Pharma, down from 0.12 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.15 in Q4 2023 and bottomed at 0.12 in Q4 2025.
  • The 5-year median for Asset Utilization Ratio is 0.13 (2021), against an average of 0.13.
  • The largest annual shift saw Asset Utilization Ratio grew 12.59% in 2023 before it decreased 14.54% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.13 in 2021, then decreased by 0.12% to 0.13 in 2022, then increased by 12.59% to 0.15 in 2023, then decreased by 14.54% to 0.12 in 2024, then decreased by 2.22% to 0.12 in 2025.
  • Per Business Quant, the three most recent readings for RPRX's Asset Utilization Ratio are 0.12 (Q4 2025), 0.12 (Q3 2025), and 0.13 (Q2 2025).